Patent ID: 9278123
Filing Date: 2016-03-08
CPC Classification: A61K,A61P

Claim Text:
1. A solid composition for oral administration comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, wherein the amount of said salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid is in the range of 0.8-1.3 mmol, and the GLP-1 agonist is N-epsilon26-[2-(2-{2-[2-(2-{2-[(S)-4-carboxy-4-(17-carboxyheptadecanoylamino) butyrylamino] ethoxy} ethoxy)acetylamino] ethoxy} ethoxy)acetyl] [Aib8, Arg34] GLP-1(7-37).